184 related articles for article (PubMed ID: 21904396)
21. [RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer].
Peralta-Zaragoza O; Bermúdez-Morales VH; Madrid-Marina V
Rev Invest Clin; 2010; 62(1):63-80. PubMed ID: 20415061
[TBL] [Abstract][Full Text] [Related]
22. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1.
Tyagi A; Vishnoi K; Mahata S; Verma G; Srivastava Y; Masaldan S; Roy BG; Bharti AC; Das BC
Clin Cancer Res; 2016 Aug; 22(16):4170-84. PubMed ID: 26988248
[TBL] [Abstract][Full Text] [Related]
23. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
24. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
[TBL] [Abstract][Full Text] [Related]
27. [Inhibitory effects of human papilloma virus 18 E6 gene in HeLa cell transfected with shRNA].
Tao GS; Zhang KQ; Chen Y; Nie MF; Liu FY; Wu YL; Liu YZ; Wu XS
Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):693-6. PubMed ID: 16277903
[TBL] [Abstract][Full Text] [Related]
28. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
29. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
30. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
[TBL] [Abstract][Full Text] [Related]
31. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A
Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915
[TBL] [Abstract][Full Text] [Related]
32. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
[TBL] [Abstract][Full Text] [Related]
33. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
[TBL] [Abstract][Full Text] [Related]
34. Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression.
Poljak-Blazi M; Jaganjac M; Sabol I; Mihaljevic B; Matovina M; Grce M
Toxicol In Vitro; 2011 Feb; 25(1):160-6. PubMed ID: 21044880
[TBL] [Abstract][Full Text] [Related]
35. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
37. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression.
von Knebel Doeberitz M; Gissmann L; zur Hausen H
Cancer Res; 1990 Jun; 50(12):3730-6. PubMed ID: 1692767
[TBL] [Abstract][Full Text] [Related]
38. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
39. Silencing of N-Ras gene expression using shRNA decreases transformation efficiency and tumor growth in transformed cells induced by anti-BPDE.
Zhou L; Jiang Y; Tan A; Greenlee AR; Shen Y; Liu L; Yang Q
Toxicol Sci; 2008 Oct; 105(2):286-94. PubMed ID: 18567617
[TBL] [Abstract][Full Text] [Related]
40. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
Braun L; Dürst M; Mikumo R; Gruppuso P
Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]